Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Syra Health secures Nebraska staffing contract

EditorEmilio Ghigini
Published 02/22/2024, 08:57 AM
© Reuters.
SYRA
-

CARMEL, Ind. - Syra Health Corp. (NASDAQ: SYRA), a healthcare consulting firm, has expanded its operations to Douglas County, Nebraska, by securing a contract to provide temporary nursing staffing services. This agreement, announced today, marks the company's entry into its 16th state.

The contract with Douglas County, which encompasses Omaha, the state's largest city, is part of Syra Health's broader mission to enhance healthcare accessibility and quality through its services and technology solutions. The company's CEO, Dr. Deepika Vuppalanchi, expressed enthusiasm for the partnership with Douglas County and the opportunity to impact the community positively.

While financial details were not disclosed, the revenue from this contract will depend on the number of nursing positions filled and the length of the staffing terms. Syra Health offers a range of products and services, including those focused on behavioral and mental health, digital health, and population health, aimed at prevention, improved access, and affordable care. The firm works with various clients, including payers, providers, life sciences organizations, academic institutions, and government entities.

Investors are cautioned that certain statements in the press release regarding future expectations and plans may constitute forward-looking statements. These include anticipated outcomes from the contract and the company's operational strategies and financial projections. As with any forward-looking statements, they are subject to risks and uncertainties, and the company's actual results may differ materially.

The announcement reflects Syra Health's continued growth and commitment to expanding its healthcare workforce solutions across the United States. The information for this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.